The Society of Practising Veterinary Surgeons (SPVS) reports that its annual Congress, held jointly with the Veterinary Practice Managers Association (VPMA) at the Celtic Manor Resort in Newport last week, was a sell out.
Over 470 delegates attended, of which 40% were practice owners, 40% were vets, 30% were practice managers and 10% were nurses.
Held over two days, the line-up of speakers included TV presenter, expedition leader, leadership trainer and ex-Royal Marine, Monty Halls who opened Congress with a talk on the importance of pushing your own personal boundaries. Psychiatrist, broadcaster and journalist, Dr Max Pemberton presented a guide to mental health problems for vets and managers. Celtic Manor’s head of 5 Star Service Delivery, Michael Pagnotta, explained how they ensure all their staff operate to the same consistently high level of service provision and Ian McKelvie, CEO of US consultancy, Becauz, presented a number of leadership and management sessions.
VetSurgeon.org visited the commercial exhibition and ask a random selection of exhibitors: "What's New?"
This is what they said:
John Kenward MRCVS, a director of Maidstone practice Pet Emergency Treatment Services, has been given a conditional discharge for allowing an employee to X-ray her own foot after a horse stamped on it.
Maidstone Magistrates heard that the employee, a 25 year-old vet and equine intern, was afraid the foot was broken and she might be unable to do that evening's on-call duty.
As a result, she rang Mr Kenward. As they were both concerned she could be held up in hospital A&E, Mr Kenward suggested she use the in-house X-ray kit. He gave her the settings to use and she carried out the test, which showed no break so she continued to work as normal.
Another director, who acts as Radiation Protection Supervisor, later noticed a human image on the digital processor. This led him to notify other practice board members of his intention to interview staff about the suspected breach of site radiation safety policy. He was immediately told by Mr Kenward not to discipline the vet intern as he had suggested that she use the X-ray.
As a result the Health and Safety Executive was contacted and an investigation confirmed a breach of radiation regulations.
Although the vet intern, from Maidstone, was the only person present during the X-ray exposure, she did not wear a personal dosemeter during the procedure.
However, HSE told the court that Mr Kenward was fully aware that the rules of the practice clearly stated nobody should be placed within the beam of the X-ray machine.
Mr Kenward was ordered to pay £1,296 in costs after admitting a breach of the Health and Safety at Work etc Act 1974.
After the hearing, HSE inspector Rob Hassell said: "Any vet practice using ionising radiation for medical exposures must ensure that the X-ray equipment is properly maintained and that the requirements of the Ionising Radiations Regulations are complied with. The view of HSE and the Department of Health is that it is highly unlikely that all these conditions can be met by a veterinary practice.
"It follows therefore that X-rays must not be taken of human beings at practices. We are aware that the X-raying of people may not be unique to this particular practice so I hope others will take note that HSE is prepared to prosecute if such breaches come to light."
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
A new book written by a man who is both married to and brother of a veterinary surgeon (not the same one, I hasten to add), offers a husband's take on a vet's life.
Author Steve Ankers is married to Margaret Ankers MRCVS (Acorn Veterinary Surgery) and brother of John Prescott MRCVS (now retired, but remains a consultant to Robson & Prescott).
His book, called It's a Dog's Life for the Other Half, is brimfull of funny anecdotes, including: holding hands with a famous actress inside a cow's rectum; a dog who ate a Cliff Richard cassette; a cat who ate a Chihuahua but spat out the tail and a vulture who travelled hundreds of miles on a car roof-rack.
Terry Jones (you know, the Python) described the book as "Hilarious and eminently readable".
It's a Dog's Life for the Other Half may be the literary equivalent of a busman's holiday for the members of this site, but I'm half way through and it's one of those rare books that's guaranteed to bring a smile to your face at least once a page.
It's a Dog's Life for the Other Half is available now from all good bookshops, including Amazon RRP £12.99. It is also available as an e-book.
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
Reference
Virbac has announced that it is to support the work of Glasgow student vets buy supplying their homeless project with vaccines and parasiticides.
'Trusty Paws' was set up last year by fourth year veterinary student Ruby Shorrock and a group of her fellow students to provide basic veterinary care to dogs belonging to homeless people in Glasgow.
Working with organisations which help the homeless, the students provide monthly clinics during which they give free vaccinations and flea/worm treatments to animals owned by the homeless. They also microchip them and give out bedding, food and clothing for the dogs and their owners.
Virbac is providing its Canigen DHPPi and Lepto vaccines to Trusty Paws, as well as its recently launched Milpro wormer and its Effipro spot-on flea treatment.
Royal Canin is also supplying marketing assistance to help Trusty Paws spread its good pet-care message and encourage those in need to visit the clinic. They will also provide clinical diets to those pets in need of specialised nutrition.
Ruby Shorrock: " Glasgow is in desperate need of this service as there is very little in place to help homeless people with animals - not even a dog-friendly hostel. We provide preventative care for their dogs in a friendly environment where they can also have a warm drink, a sandwich and a chat. We rely on fundraising and donations to keep the clinics running and also fundraise to help any dogs with major health problems so that they can made more comfortable for their hard life on the city's streets.
"For many homeless people, their dogs are a treasured companion. Protecting them from disease and parasites is the most important thing we can do to help them continue to benefit from this companionship.
Simon Boulton MRCVS, Head of Marketing (Companion Animal Business Unit) at Virbac, said: "In setting up Trusty Paws, Ruby and her colleagues are providing a vital service to animals in dire need of basic veterinary care. They are also extending the hand of friendship and support to homeless people in Glasgow, who already face a difficult life and value the unconditional love they get from their pet so highly. We were inspired by the fantastic work they are doing and are delighted to support them by donating our vaccines and parasite control products to them."
The Animal Health Trust and the Kennel Club have announced that a new, non-invasive DNA test for the genetic mutation causing macular corneal dystrophy (MCD) in Labradors will be available from the Animal Health Trust DNA Testing Service from Monday 26 January 2015.
Macular corneal dystrophy (MCD) is a hereditary eye disease which, although painless, causes severe visual impairment in affected dogs.
The mutation for MCD is recessive; meaning only dogs that inherit two copies of the mutation will be affected. Dogs identified by the test as Clear have no copies of the mutation whereas Carriers have one copy of the mutation. Clears and Carriers cannot develop MCD, although Carriers will pass the mutation on to about half of their puppies if they reproduce. Dogs identified as Genetically Affected have two copies of the mutation and will develop MCD around middle-age. The DNA test can be used to screen dogs at any age and provides a means of eliminating the causal mutation from the Labrador Retriever gene pool.
Dogs affected with MCD will develop cloudy eyes, due to an abnormal accumulation of carbohydrates (known as glycosaminoglycans) in their corneas. The only treatment for the disease in people is to surgically perform a corneal transplant; however this has not yet been performed successfully in the dog for the treatment of MCD.
Dr Cathryn Mellersh, Head of Canine Genetics at the Animal Health Trust, said: "We're really pleased to be able to provide this new test in 2015. Screening Labradors for the mutation responsible for this condition will help to identify those dogs at risk of developing MCD, and/or passing it on to their puppies. Dogs don't typically develop MCD until middle age - so without a DNA test there is a chance that affected dogs are unknowingly bred from. Now, affected and carriers dogs can easily be identified through one simple test giving breeders peace of mind.
"By developing this test and encouraging screening within the Labrador population we hope that this horrible disease can now be eliminated from the breed. This is the aim behind all of our work in canine genetics and we're thrilled to have been able to make such good progress in developing this test after MCD was first reported in Labradors by one of own veterinary ophthalmologists in 2013. Since then we've worked closely with the ophthalmology team here at the Animal Health Trust and Labrador owners and breeders from various European countries and have managed to identify the mutation and launch this test within two years, which is great news for Labrador owners."
Caroline Kisko, Kennel Club Secretary, said: "The Labrador is the most popular breed in the UK, so there is certainly a high demand for puppies, and it is crucial that those being bred are as healthy as possible.
"This test will further assist breeders of Labradors in breeding healthy, happy examples of the breed and we are delighted to be able to offer another tool to improve and maintain the breed's health.
"The work carried out at the Kennel Club Genetics Centre at the Animal Health Trust really does make a massive difference to the lives of dogs and we are thrilled that Labrador breeders will now be able to make use of another health test to protect the health of the breed they love."
For more information, visit www.ahtdnatesting.co.uk. The test costs £48 inc VAT, with a 10% discount when at least 20 samples are submitted within a month. Interested parties should contact dnatesting@aht.org.uk with a start date to request a discount code.
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, has opened a new discussion exploring the issue of mental health problems.
The discussion has been opened by this month's Vet Futures guest blogger, Rosie Allister, Chair of the Vet Helpline and a Director of the Veterinary Benevolent Fund.
Rosie, who is also a researcher at the University of Edinburgh specialising in veterinary wellbeing, writes that members of the profession should be more willing to open up about their own mental health problems and intervene by talking and listening to colleagues who may be suffering from mental ill-health. She said: "Looking to the future, we need to better understand who is most at risk, how to reach out to them, and how we can start to change our culture so that it is OK to ask for help."
Her blog also proposes that, due to the caring nature of the occupation and high client expectations, members of the profession routinely put work and animal welfare ahead of their own needs and that, in order for there to be wider cultural change, individuals need to change their own attitudes towards asking for help. This includes the discussion of 'taboo subjects' such as suicide: "Perhaps all of us have to start trying to change our culture to one that is more accepting and supportive and looks out for those in need even when they aren't able to reach out themselves."
As part of the discussion, Vet Futures is running a poll which asks: "Could you recognise the signs of mental ill-health in a colleague?"
To read Rosie's blog and take part in the poll, visit and take part in the poll, visit: http://goo.gl/EmLhhF
Veterinary Insights has announced that it will be unveiling Vet Viewer, its new veterinary benchmarking service, at the SPVS/VPMA event at the Celtic Manor Resort, Newport, South Wales on January 22-24.
As those familiar with the old Fort Dodge Indices will be aware, benchmarking services like these allow participating veterinary practices to compare their own activity and business results against a broad panel of similar veterinary practices so that they can better gauge their own market performance and make changes to their working practices as they see fit.
Vet Viewer is provided free of charge to participating vet practices. It delivers monthly information to help practices get a quick understanding of key business metrics and a clear view of practice activities and the income they are generating.
Veterinary Insights' Managing Director Alexander Arpino said: "The Benchmarking Service has been carefully designed to give practical business support to veterinarians and we have had a great response from the 100 plus clinics that have signed up to the service to date. We have plans to expand the range of services offered to enable an even wider range of meaningful data and KPIs for veterinarians to manage their businesses."
The incoming President of the Society of Practising Veterinary Surgeons (SPVS), Nick Stuart said: "We have been working closely with Veterinary Insights for over a year on this valuable service and we are delighted to say that SPVS members will have access to additional features that track practice profitability and other important financial measurements."
For further information contact Veterinary Insights on 01403 800135 or visit: www.vetviewer.co.uk
Additionally you can download a detailed brochure on the Benchmarking Service here: http://www.vetviewer.co.uk/downloads/vet-viewer-brochure.pdf
Pets'n'Vets, a Glasgow-based partnership, has revealed plans to open what it describes as the city's first veterinary 'super practice'.
Located at a 7500 sq ft customised facility in the Auldhouse Retail Park in Pollokshaws, The Roundhouse Veterinary Hospital will provide comprehensive pet care seven days a week, caring for animals around the clock and providing late night consultations when required. Pets'n'Vets says it believes it will deliver a step change to the standard of veterinary care available in the city.
Pets'n'Vets partner Oliver Jackson said: "Having provided excellent veterinary care to the Southside's pets for over 40 years we feel that this will create a cutting-edge facility in which to do so for the next 40 years.
"Our plans for this ambitious new facility have been modelled on the American concept of a vet 'super-practice', designed to deliver the whole suite of pet care services, from nail clipping to vaccinations to some of the most complex surgical veterinary procedures - and will provide these services locally, at sensible cost and to the highest clinical standards with one of the best qualified, first opinion veterinary surgeons in the West of Scotland and one of the best medical experts too.
"This is a really exciting initiative that will bring a real first to Glasgow. It will enable us to care for animals 24 hours a day as there will be nursing staff living on-site so that animals can receive continuous treatment through the night. The location of the facility means that pet owners and, more importantly, sick animals, will not have to travel too far and, given the size and scope of the facility, we expect to be able to reduce significantly the waiting list before veterinary procedures can be scheduled.
"The whole idea behind The Roundhouse Veterinary Hospital is that we will be in a position to provide continuous lifelong veterinary care regardless of the problems that life brings - our vets and nurses often first meet our friends and their pets as a puppies, kittens and kits and we get to know pet and owner exceptionally well over the years - in the event that that pet requires a complex surgical procedure or in-patient medical care, we want to be able to offer that too, rather than the pet and owner being referred to an unfamiliar veterinary hospital.
"A particularly exciting aspect of the development is that some of the services will be led by our qualified veterinary nurses in conjunction with the surgeons. To facilitate this, the practice will in addition to the vet consulting rooms, house two specialist nurse consulting rooms."
The Roundhouse Veterinary Hospital will feature a cat examination room which, unusually, will not feature a consult table. Instead, this new facility will feature steps and an artificial tree that will enable the nurse or vet to better assess its movements.
Partner Oliver Jackson said: "This is an ultra-modern arrangement which is aimed at allowing us to examine cats in a more natural way - we hope that this will assist us to diagnose many more cases of feline arthritis, a disease that a recent study accepted was often missed by the traditional, consulting table means of examining cats."
Similarly, the dog room will not feature a consult table but will have facilities for physiotherapy or play - and there will be a special garden enclosure for exercising any dogs requiring to stay at the facility for any length of time.
The 'super practice' will feature separate cat and dog waiting and consultation rooms as well as separate in-patient wards to reduce stress. In the clinical wing, the facility boasts two sterile theatres, specified to the highest clinical standards, with a separate scrub area, a designated dental theatre, large patient preparation area as well as state-of the art diagnostic suites.
Pets'n'Vets says the hospital design has been carefully considered to encourage the best possible clinical care. For example vets' stations overlook the intensive care unit and the preparation area remains open plan, taking advantage of natural light provided by a large overhead atrium, whilst specialist air extraction systems ensures sterility by separating the area into clinical zones.
In addition to the dog and cat accommodation the hospital will also have an isolation ward which will be separate for any animals with potentially contagious diseases and a ward dedicated to less usual pets with facilities for everything from rabbits and guinea pigs to albino hedgehogs as well as vivaria for looking after reptiles.
The Roundhouse Veterinary Hospital will also feature a private area for pet owners needing to spend a little more time, perhaps on those sad occasions when a pet has to be put to sleep, as well as a dedicated and more relaxed room where owners will be able to discuss the health of their pet with the vet.
Oliver said: "We want The Roundhouse to be a place for learning and meeting, so there will be a coffee station for owners and a homely, relaxed and welcoming feeling. We're also planning to host school trips and the facility will feature a little veterinary practice where kids can play, with stethoscopes and little white coats for them to wear.
"As a practice, Pets'n'Vets has always been very involved in training and this new facility will enable us to do that on an unprecedented scale. Our ambition is that The Roundhouse will become a drop-in centre for people to come with their animals to learn and to play as well as to receive medical treatment."
The Roundhouse Veterinary Hospital will create six additional full-time jobs when it opens this summer. Pets'n'Vets says that many of the treatments currently delivered by its nearby surgery on Pollokshaws Road will transfer to the new facility, enabling it to create Glasgow's first dedicated vaccine clinic at the old surgery.
Centaur Services has announced a new partnership with VBS Direct which will allow the wholesaler to offer USA-based K-Laser products to its customers for the first time.
According to VBS, the K-Laser range can be used to treat a wide range of conditions. However, the company says most practices choose to buy K-Laser so they can start osteoarthritic pain management clinics and improve post-surgical rehabilitation, often using trained nurses or physiotherapists to run the clinics.
Centaur says K-Laser offers the most advanced Class IV therapy laser platform in the world, with the team of scientists and doctors at K-Laser USA having researched, tested and implemented therapy presets that are categorised anatomically and subdivided by clinical indication. The company claims that during treatment, laser energy is absorbed in water, increasing local circulation and thereby drawing oxygen and nutrients to the damaged area. This, it says, creates an optimal healing environment that reduces inflammation, swelling, muscle spasms, stiffness and pain.
Apparently, more than 8,000 US veterinary practices and almost 100 in the UK have invested in Class IV laser therapy.
Colm McGinn from Centaur said: "We're committed to finding innovative products and services for our customers so that we can help them to grow their businesses and succeed together.
"K-Laser, as well as being a revolutionary piece of clinical equipment, is also a fantastic revenue generator for veterinary practices and with our flexible payment options our customers are able to reap the benefits to their businesses very quickly. We appreciate that making capital investment in equipment can be a big decision and we want to fully support our customers in improving the services their practices can offer."
For more information, contact Centaur on 01963 350005 or VBS Direct on 0845 528 0336.
Ceva Animal Health has announced the launch of Vectra Felis, a new spot-on flea treatment for cats.
The new product contains two active ingredients: dinotefuran and pyriproxyfen. The first is an adulticide which Ceva says kills fleas on contact, thereby stopping fleas biting before they die. The second ingredient is an Insect Growth Regulator (IGR) which prevents flea reproduction and adult flea emergence, so protecting the cat and its environment from future flea attacks.
According to the company, Vectra Felis ensures that over 95% of fleas are killed within two hours and the effects last for a month.
In addition, Ceva highlights the product's patented applicator, which has an elongated smooth tip for quick and easy application. The company says it also provides accurate dosing and facilitates clean administration as nothing comes out until the tube is squeezed. Kittens can be treated from seven weeks of age (weighing at least 0.6kg).
For further information on Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
Merial has announced the UK launch of updated ProteqFlu, the first and only EI vaccine in Europe to contain a clade 2 strain.
The company says the new vaccine is also the only one that is fully compliant with the latest 2014 OIE recommended EIV strains.
Louise Radford MRCVS from Merial said: "The launch marks the UK's first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen which includes protection against the latest Florida Clade 2 strain, Richmond 07. This is a significant step for horse health, and the equine industry as a whole."
Hervé Poulet, Merial's head of BioDevelopment and BioResearch said: "Merial has developed strong and unique expertise in the development of non-replicative recombinant canarypox virus-vectored vaccines for various species and diseases.
"For the development of ProteqFlu, our non-replicative recombinant canarypox vector expressing the EI virus haemagglutinin (HA) is used because of its ability to induce a strong cellular immunity which is an essential component in protecting against this highly contagious disease."
Louise added: "ProteqFlu has also demonstrated its success and efficacy in real outbreaks, particularly during the last major outbreak, in Australia in 2007. ProteqFlu was the only vaccine chosen for the eradication programme."
Ceva Animal Health has made a last call for anyone to nominate a veterinary professional, charity worker or volunteer for one of its Animal Welfare Awards.
The awards are designed to help identify and celebrate the people who work to help better the lives of animals
The deadline for nominations is 13th January 2015, after which entries will be judged by a panel of industry professionals, including Christopher Laurence MBE BVSc. The 2015 ceremony will once again be taking place at BSAVA.
Awards judge, James Yeates, Chief Veterinary Officer of the RSPCA, said: “There is a growing welfare crisis that is faced by many animals across the world, and part of the answer to these issues lays in the important role that charities, vets and volunteers play in helping improve the lives of animals every day.
“These awards allow us the opportunity to recognise these people for the great work that they do, and hopefully help to inspire others to exercise the same level of dedication to animal welfare. Help us to make sure the selfless welfare heroes in your community are recognised by nominating them at www.cevawelfareawards.co.uk.”
The full list of award categories is:
VetsSouth, the new CPD congress and commercial exhibition being held in Exeter on 11th and 12th February, has announced that it will lead with a discussion about what practices can do to reduce bovine TB in clients' herds in 2015.
The congress, which is open to practising vets throughout the UK but aimed specifically at those in the west and south of the UK, will have three-and-half hours of discussion led by Roger Blowey (pictured right) and Richard Gard, with contributions from a number of practices in Gloucestershire, Devon, Somerset and Cornwall.
During a day on "cattle" on the Wednesday, Roger Blowey will also lead two sessions on "Recent dramatic changes in our understanding of cattle lameness", covering anatomy and foot lesions in the first and moving on to digital dermatitis and other infectious lesions in the second.
The rest of the programme is concerned mainly with small animals, the line-up of speakers including Dr David Williams on ophthalmology, Matthew Oxford on dentistry, Dr Andy Sparkes on feline medicine and surgery, Sarah Health on canine and feline behaviour and Anthony Chadwick on dermatology; plus six speakers from the Bristol veterinary school: Dr Jo Murrell and Gwen Covey-Crump on pain management, Dr Domingo Casamian Sorrosal and Dr Sonia Fonfara on cardiology, and Guillaume Chanoit and Ivan Doran on soft tissue surgery.
In addition, Professor John and Mrs Margaret Cooper will lead a day-long seminar on veterinary forensic medicine; the VDS will be running half-hour one-on-one sessions on improving consultation techniques; and there will be workshops on "ocular examination and pathology", "cat-friendly clinics" and "practical tooth extraction".
Exhibitors include Langford Veterinary Services, Vets4Pets/Companion Care, Protexin, Summit Veterinary Pharmaceuticals, Dechra Veterinary Products, Royal Canin, Bayer Animal Health, Natures Menu, Pet Medic Recruitment/Mi Vet, Teignview Veterinary Group, Henry Schein Animal Health, Axiom Veterinary Laboratories, iM3 Dental, Medimark Scientific, Merial Animal Health, Nova Laboratories, Improve International, DVH Veterinary Sales, Centaur Services, A. Menarini Diagnostics, The Webinar Vet and Improve International.
The event is being run by VP CPD in association with Improve International and The Webinar Vet, with generous sponsorship from Dechra Veterinary Products. Attendance on both days is priced at £145 (plus VAT); one-day passes cost £80 (plus VAT) with additional charges for the workshops and VDS sessions. The prices include speaker notes, refreshments throughout each day and a buffet lunch. CPD certificates will be sent on request after the event.
Full details and a booking form are on www.vetssouth.com.
CVS has announced a two year programme of investment of more than £3 million in two high-field (1.5 Tesla) MRI scanners and seven CT scanners as part of a programme to provide advanced imaging resourcing across the group.
The first of the MRI scanners will be installed at ChesterGates, CVS' multi-disciplinary veterinary referral hospital, in Spring 2015. CVS says it believes it will be the most advanced MRI system for pets in the North West of England.
The seven 16-slice CT scanners will be installed at CVS hub practices, including ChesterGates, PetMedics in Manchester, Beechwood Veterinary Hospital in Doncaster and St David's in Devon.
CVS Referral Director John Innes said: "We are committed to utilising the latest technology across the group and this investment in our scanning capability is a good example. The new MRI scanner at ChesterGates will enhance the high quality specialist referral services we offer, particularly in neurology because MRI is used mainly to image the brain and spinal cord.
"The seven new CT scanners will enable our teams to scan a chest or abdomen rapidly and with outstanding image quality. Image data can be processed and viewed in other planes or 3-D rendered to assist with decision making and surgical planning. The installation of the new CT scanners will be rolled out over the next two years, enabling us to offer cost-effective advanced imaging to many more of our clients across the country."
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-prick sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
Norbrook Laboratories has announced the launch of Cefimam LC intramammary ointment for the management of mastitis.
Norbrook's large animal vet adviser Stephanie Small MRCVS said: "With such a broad range of treatments to choose from, vets are able to choose the product which best fits the situation. Cefimam® LC brings a powerful antimicrobial to the mix with high penetration for more difficult mastitis cases. Only three applications are required, which means fast resolution and rapid return of affected animals to production.
"This company firmly supports the large animal sector: as well as our commitment to making effective treatments affordable, we are investing in the future of the industry. We have worked closely with leading dairy vets to produce best practice materials for farming clients, and there are more educational tools in development."
Amongst these is a new guide called The Best Practice Guide for On-Farm Mastitis Control which you can now get from your Norbrook Territory Manager.
Cefimam LC is now available at all veterinary wholesalers in packs of 24 x 8g intramammary tubes.
For further information on Cefimam® LC, contact Senior Product Manager Chris Geddes MRCVS on 01536 741147
Elanco has announced that it has finalised its acquisition of Novartis Animal Health.
The acquisition, announced in April last year, follows Elanco's purchase of Lohmann Animal Health earlier in 2014. It swells Elanco's portfolio to nearly 300 brands encompassing therapeutics, vaccines, parasiticides, antimicrobials, surgical, enzymes, food safety and more.
Gaynor Hillier, Elanco's General Manager UK and Ireland said: "Elanco's acquisition of Novartis Animal Health brings together two strong companies with a passion for serving the customer. We will continue to offer the products our customers trust, while significantly investing in the development of new solutions to meet our customers' greatest unmet needs."
The company says it will now increase investment in research and development significantly, with a combined portfolio of more than 100 product development projects focused on:
Gaynor added: "We'll continually seek innovative ways we can support our customers' business. With increased technical services, that combine our analytic and benchmarking tools with on-the-ground support, we'll be able to spend more time with individual customers seeking innovative solutions that can make a difference in their business."
Elanco says that the complete integration of the businesses will take some time, but it is trying to make the transition seamless. For the foreseeable future, business will continue in much the same way, including product ordering and customer support. Availability and access to products will continue uninterrupted.
For more information about the acquisition, visit www.elanco.com.
A North Wales-based enviro-tech company called Streetkleen has launched PooPrints, a DNA test used to identify the dogs responsible for leaving faeces in public places, in the UK.
Dogs are first added to the DNA World Pet Registry by taking a cheek swab and sending it for analysis at a cost of £29.95. Local authorities and landowners can then test any stray dog mess they find and see if the culprit is on the database, at a cost of £69.95.
Of course it does beggar the question why pet owners would agree to have their dog added to the database (and pay for it).
Streetkleen believes that new new legislation: The Anti-Social Behaviour, Crime and Policing Act 2014, which gives communities the opportunity to set conditions to help prevent nuisances such as dog fouling, would allow local authorities to require all dogs that use a park, for instance, to be registered.
According to the company, having the PooPrints program operational has led to a drop of 90% in recorded dog fouling incidents in many locations as dog owners realise they can be held accountable.
Streetkleen Managing Director Gary Downie said: "As a dog owner myself the challenge was how do we combine positive dog ownership with access to open spaces whilst ensuring we have accountability to local dog policy? PooPrints is a cost effective, permanent solution to dog fouling that helps ensure that our open spaces are clean, safe and welcoming for dog owners and non-dog owners alike."
The RCVS is to launch a consultation in the New Year on proposals to allow all RCVS-registered veterinary surgeons to use the courtesy title 'Dr'/'Doctor', and is seeking the views of all members of the veterinary and veterinary nursing professions, and the general public.
The proposals were raised by RCVS President Stuart Reid at RCVS Day in July 2014, with the aims of aligning the UK with international practice, providing greater clarity for the profession and offering reassurance to clients and the animal-owning public that all veterinary surgeons registered with the RCVS, regardless of where they qualified, have veterinary degrees of an appropriate standard.
In his speech in July, Stuart highlighted that most international veterinary surgeons use the title and that, in Australia and New Zealand, this is frequently tied to registration and professional standing, rather than necessarily academic attainment. He went on to outline that, of the three main clinical degrees in the UK, ie medicine, dentistry and veterinary medicine, only veterinary surgeons do not use the courtesy title 'Doctor'.
Stuart added: "given the fact that all continental EU graduates carry the title 'Doctor', there is now a greater chance of confusion for the lay public than previously.
"This is now an opportunity to provide, for those UK veterinary surgeons who wish it, the legitimate use of a title that offers a level of parity with fellow medical professionals."
The key objective of the consultation is to gauge whether the public and the profession are in favour of the proposal, not in favour of it, or don't mind either way. If agreed, the use of the title would be optional, although the College would regulate its use through the RCVS Code of Professional Conduct.
Background information and draft guidance on using the title is available to read on the RCVS website at www.rcvs.org.uk/doctortitle, from where respondents can follow a link to answer the consultation questions.
The consultation will open officially on Tuesday, 6 January for six weeks (deadline for responses is 5pm on Monday, 16 February) although it is already available to view via the RCVS website, to allow more time for responses over the Christmas and New Year break.
Do you think vets should be called 'Dr'? Discuss here.
The Veterinary Benevolent Fund (VBF) has announced that the new Vet Helpline, which will now be answered by a live person 24 hours a day, has launched in time for Christmas - an especially difficult time for many people.
The new service runs on a new telephone number: 0303 040 2551. Add it to your address book now, if not for yourself, in case you need to pass on the information to a colleague who needs help.
The new Vet Helpline has been made possible with support from the new RCVS joint initiative “Mind Matters”
Rosie Allister, Chair of Vet Helpline said: “It’s so important that people who take the brave and positive step to seek help by calling Vet Helpline are able to connect with one of our trained volunteers as quickly as possible. We know many are deterred by reaching a voicemail, so connecting to a human being is vitally important and can have an important positive impact. We are so grateful for this vote of confidence in Vet Helpline from the Mind Matters initiative.
"Everyone involved in running Vet Helpline is a volunteer and the team is so incredibly passionate and keen to see the service continually improve. The launch of our confidential e-mail service last year, which hides all email addresses (accessible via www.vetlife.org.uk), was a huge positive step forward and now this evolution to live answering is another. We are adamant that although the phone number is changing, the non-judgmental, completely confidential and empathetic support that we offer will not."
As one of the four arms of support offered by the VBF, Vet Helpline sits alongside services offering financial support, help with mental health conditions, including drug and alcohol addiction, and a library of resources aimed at promoting well-being on the Vetlife website - www.vetlife.org.uk.
Ceva Animal Health has launched a new national TV advertising campaign to raise awareness of the benefits of its veterinary behaviour product Feliway amongst cat owners.
Featuring the strapline 'Transforming behaviour begins with Feliway', Ceva says the advertisement will educate cat owners on the action they should take to keep their cats happy and maintain a happy home, particularly in multi-cat households where inter-cat tension may be a problem. It focuses on the real life testimonial of a pet owner and the challenges of introducing a new cat to a household.
The 30 second advertisement, which is aimed at ABC1 women, will air from Christmas Day until Sunday 11 January. It will be featured on ITV1, Channel 4, Channel 5, digital channels including E4, Film4, ITV2, ITV3 and ITVBe and London Live.
For further information on Feliway visit feliway.co.uk.
The World Veterinary Poultry Association (WVPA) has announced that nominations are now open for its Young Poultry Veterinarian of the Year 2015 Award, sponsored by Zoetis.
The award, now in its fourth year, is open to qualified poultry veterinarians who are under the age of 35 on January 1, 2015. The winner will be selected by a global panel of judges and will receive a USD$5,000 contribution towards attending international scientific or continued professional development meetings.
The WVPA is calling for nominations to be made on behalf of young veterinarians who have excellent poultry diagnostic and advisory skills, are effective communicators and transferors of their knowledge and can demonstrate a real passion for their industry.
Nigel Horrox, vice president of the WVPA said: "We continue to be impressed by the calibre of entries for this award, and we are confident that this year will be no exception.
"We are looking for an individual who is not only invaluable to their local poultry industry, but who consistently goes above and beyond the call of duty and is a credit to their profession."
Hector Badillo, group director of global marketing at Zoetis, said the contribution made by young poultry veterinarians is vital to the future of the industry. "We are proud to support this award, which recognises top new talent in the global poultry industry and the outstanding contribution made by an individual."
Entries for the award are to be made via the dedicated website: www.wvpa-award.com. Nominees/applicants are asked to describe in 500 words or less their role and achievements in the industry and why they feel they should win the award. The award will be presented at the XIX Congress of the World Veterinary Poultry Association, Cape Town, South Africa, September 7-11, 2015.
Closing date for entries is March 31, 2015.
Boehringer Ingelheim Vetmedica Ltd has announced that Metacam is now available for use in pigs as an oral suspension.
Metacam, which contains the non-steroidal anti-inflammatory drug (NSAID) meloxicam, is indicated for the treatment of non-infectious locomotor disorders to reduce inflammation and signs of lameness. It is also licensed for the treatment of mastitis-metritis-agalactia (MMA) syndrome in sows, when used alongside appropriate antibiotic therapy. MMA is a multifactorial condition that can threaten the health of the sow and the lives of her piglets due to a marked decrease or complete cessation in milk production.
Boehringer says treatment with Metacam15 mg/ml oral suspension helps control inflammation and pain associated with the condition, thereby helping to restore productivity and wellbeing in the sow and her offspring.
Metacam 15mg/ml oral suspension for pigs supplements the existing injectable formulation and has been introduced to its increase flexibility and ease of use, and to reduce the potential stress than can be caused when injecting newly-farrowed sows. The palatable suspension can be given mixed with a small quantity of feed or can be administered directly into the mouth.